A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides

Autor: Mikko Vahermo, Lluís Ballell-Pages, Antti Siiskonen, Leena Keurulainen, Benigno Crespo-Fernández, Pablo Castaneda-Casado, Félix Calderón, Laura de las Heras-Dueña, Teppo O. Leino, Laura M. Sanz, Paula Kiuru, Laura Guijarro-López, Jari Yli-Kauhaluoma, Margarita Puente-Felipe, Sara Viera, Elena Sandoval-Izquierdo, Leticia Huertas-Valentin, M. Belen Jiménez-Díaz, Maria Santos Martinez-Martinez
Rok vydání: 2015
Předmět:
Zdroj: Journal of Medicinal Chemistry. 58:4573-4580
ISSN: 1520-4804
0022-2623
Popis: Malaria continues to be a major global health problem, being particularly devastating in the African population under the age of five. Artemisinin-based combination therapies (ACTs) are the first-line treatment recommended by the WHO to treat Plasmodium falciparum malaria, but clinical resistance against them has already been reported. As a consequence, novel chemotypes are urgently needed. Herein we report a novel, in vivo active, fast-acting antimalarial chemotype based on a benzimidazole core. This discovery is the result of a medicinal chemistry plan focused on improving the developability profile of an antichlamydial chemical class previously reported by our group.
Databáze: OpenAIRE